SCHEMBL8744204

SCHEMBL8744204

Cc1cn([C@]2([SiH](C)C)O[C@H](CO)[C@@H](O)C2C(C)(C)C)c(=O)[nH]c1=O

nearest known ligand 0.43

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
TK1 P04183 5/20 0.40
TK2 O00142 2/20 0.37
LMNA P02545 3/20 0.37
TSHR P16473 2/20 0.37
ALB P02768 2/20 0.37
BLM P54132 2/20 0.37
TYMP P19971 1/20 0.37
PKM P14618 1/20 0.37
PMP22 Q01453 1/20 0.37
CYP2D6 P10635 1/20 0.37
ALDH1A1 P00352 1/20 0.37
POLB P06746 1/20 0.37
ADRA1A P35348 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8987848 0.90 TK1 (0.36) TK1TK2LMNAALBBLM
SCHEMBL8744146 0.87 TK1 (0.39) TK1LMNATSHRALBBLM
SCHEMBL9396549 0.86 RNASE1 (0.39) TK1TK2
SCHEMBL8744160 0.83 TK1 (0.36) TK1TK2TYMP
SCHEMBL7776582 0.82 SLC28A1 (0.42)
SCHEMBL8538169 0.81 TK2 (0.42) TK1TK2LMNAALBBLM
SCHEMBL28293120 0.78 LMNA (0.36) TK1TK2LMNAADRA1A
SCHEMBL9216459 0.78 ALDH1A1 (0.35) TK1TK2LMNAALBBLM
SCHEMBL28294848 0.76 ALDH1A1 (0.34) TK1TK2ALDH1A1
SCHEMBL28991368 0.76 LMNA (0.36) TK1TK2LMNAADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109661232-A NUCLEOTIDE DERIVATIVES AND METHODS OF USE THEREOF 纽约哥伦比亚大学董事会 2019-04-19 CN disclosed
CN-108779138-A Design and synthesis of nucleotides based on novel disulfide linkers for use as reversible terminators for DNA sequencing by synthesis 哥伦比亚大学董事会 2018-11-09 CN disclosed
EP-0753002-A1 MODIFIED OLIGONUCLEOTIDES AND INTERMEDIATES USEFUL IN NUCLEIC ACID THERAPEUTICS AMGEN INC. (US) 1997-01-15 EP disclosed
WO-1995026972-A1 MODIFIED OLIGONUCLEOTIDES AND INTERMEDIATES USEFUL IN NUCLEIC ACID THERAPEUTICS AMGEN INC. (US) 1995-10-12 WO disclosed